Pharmafile Logo
Pharmafocus logo
Advanced Search

Working Life: Merck Serono’s Wolfgang Wein

April 6, 2011
Research and Development, Sales and Marketing Working Life

Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …

News

John Gargiulo to lead Daiichi Sankyo in the US

April 6, 2011
Sales and Marketing appointment, sales and marketing

Daiichi Sankyo has appointed John Gargiulo as its president and chief executive in the US. He succeeds Joseph Pieroni who …

Appointment

Evil big pharma: myth or material?

April 6, 2011
Research and Development, Sales and Marketing Les Rose, industry reputation

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …

Feature

Merck acquires eyecare specialist Inspire

April 6, 2011
Research and Development, Sales and Marketing Inspire, Merck, eye care

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …

News
Boehringer Andreas Barner

Boehringer bets on Pradaxa to fill portfolio gaps

April 6, 2011
Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa

Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …

News
pfizer_belgium_kris_westelinck

Kris Westelinck appointed president of Pfizer Belgium

April 5, 2011
Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, researcha and development, sales and marketing

Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …

Appointment

ABPI appoints new head

April 5, 2011
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, appointment

The ABPI has appointed former Prudential communications director Stephen Whitehead as its new head. He joins the UK pharma industry …

News
ABPI Code of Practice

Digital Pharma: UK gets social media guidance

April 5, 2011
Medical Communications Code of Practice, Digital Pharma blog, PMCPA, digital marketing

The UK’s Code of Practice regulator has issued guidance on social media and other digital communications tools. It is the …

News
Johnson & Johnson's Tylenol

J&J reorganises McNeil as recalls keep coming

April 5, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole

Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …

News

Pfizer sells drug delivery unit Capsugel for $2.38bn

April 5, 2011
Manufacturing and Production Capsugel, Kohlberg Kravis Roberts & Co, Pfizer, pharmaceutical capsules

Pfizer has agreed to sell its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. for $2.38 billion …

News
Lansley

Government urged to slow pace of NHS reforms

April 4, 2011
Sales and Marketing GP consortia, Liberating the NHS, NHS reform

The Government should slow down its health reform programme to allow GPs to grow into their new role, the think …

News

Interphex: manufacturing product showcase

April 4, 2011
Manufacturing and Production Interphex, PTI Inspection Systems, Pall Corp

This year’s Interphex exhibition in New York featured the usual crop of new product launches from processing and packaging equipment …

News

China’s new GMP rules will lead to industry consolidation

April 4, 2011
Manufacturing and Production China, GMP

China’s new rules on Good Manufacturing Practice is likely to drive consolidation among the country’s 5,000-plus pharmaceutical companies, according to …

News

New BMS drug trumps peg-interferon alpha

April 4, 2011
Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa

Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …

News

Doubts cast on new Cancer Drugs Fund

April 1, 2011
Cancer Drugs Fund, value-based pricing

There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …

News

Angela Pasma to lead Chiltern’s new Netherlands office

April 1, 2011
Research and Development appointment, chiltern, research and development

Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …

Appointment
Amgen

Amgen’s novel lung cancer drug disappoints in phase III

April 1, 2011
Research and Development Amgen, Millennium, NSCLC, Takeda, motesanib, non-small cell lung cancer

Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …

News
GlaxoSmitKline

GSK details $28.5m of research payments to US institutions

April 1, 2011
Research and Development GSK, payments

GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …

News

TcL Pharma appoints French pharma veterans

April 1, 2011
Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment

TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …

News

NHS reforms caught in a ‘reality gap’ as dissent grows

March 31, 2011
Andrew Lansley, Liberating the NHS, NHS, NHS reform

The proposed NHS reforms are in danger of failing because of a ‘reality gap’ between the government’s ambitions for change …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026